Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
about
Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallelGastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatmentManaging Antiplatelet Therapy and Anticoagulants in Patients with Coronary Artery Disease and Atrial FibrillationEvaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.The safety of clopidogrel.Balancing antiplatelet and anticoagulant therapies in patients with cardiovascular disease.'Ins' and 'outs' of triple therapy: Optimal antiplatelet therapy in patients on chronic oral anticoagulation who need coronary stenting.Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin.Antithrombotic strategies and outcomes in acute coronary syndrome with atrial fibrillation.Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.Optimal antithrombotic strategy in patients with atrial fibrillation after coronary stent implantation.Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention.Antithrombotic Regimens for Patients Taking Oral Anticoagulation After Coronary Intervention: A Meta-analysis of 16 Clinical Trials and 9,185 Patients.Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis.Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.Mortality Risk Associated with AF in Myocardial Infarction Patients.Comparing the clinical outcomes in patients with atrial fibrillation receiving dual antiplatelet therapy and patients receiving an addition of an anticoagulant after coronary stent implantation: A systematic review and meta-analysis of observationalDual antiplatelet therapy with or without oral anticoagulation in the postdischarge management of acute coronary syndrome patients with an indication for long term anticoagulation: a systematic review.Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation.Fatal renal bleeding in a patient treated with aggressive antithrombotic therapy after recurrent coronary stent thrombosis.Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis.Meta-Analysis of Oral Anticoagulants with Dual versus Single Antiplatelet Therapy in Patients after Percutaneous Coronary Intervention.Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.Safety of dual antiplatelet therapy in daily cardiology practice.[Patient selection for the implantation of a left atrial appendage occluder in primary and secondary prevention of cardioembolic stroke in atrial fibrillation].Outcome after coronary artery bypass surgery and percutaneous coronary intervention in patients with atrial fibrillation and oral anticoagulation.Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis.Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation.Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis.Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents.Triple Antithrombotic Therapy and Outcomes in Post-PCI Patients Undergoing Non-cardiac Surgery.Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world Study.Atrial fibrillation and percutaneous coronary intervention: stroke, thrombosis, and bleeding.Combined use of warfarin and oral P2Y12 inhibitors in patients with atrial fibrillation and acute coronary syndrome.Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study.
P2860
Q26741058-7326EB64-AB3B-47E8-8A3A-111799338EC1Q27027977-4C79C8E1-5BC4-440D-98E5-4491F6D2F0EBQ28080247-40E3E699-2F04-484A-83EE-3769CD191368Q30252099-8F949E43-097E-4886-9A60-49136DB2E520Q33392895-59F4F545-8DC6-48A3-A5C1-1EB29C01BCFFQ33936118-B033DF7E-7C85-41FB-91C3-82417BEB753AQ34135274-F88C1AB5-C083-4207-97CC-190DEC75B9D1Q34793416-B4D09921-3C6D-4333-A199-25DE54EE50F7Q35026672-F82100A2-639B-4C0F-B06B-C4B966A3C254Q35235826-C3A9254F-5DFA-46E0-9D6C-4B4F8D04C67CQ35542784-E7A1753B-1D31-4C78-95AD-2FDE3C473FE8Q35566692-A470845D-FB19-46E8-A388-46885ADCE3C3Q35575189-EEBF22B7-C9A9-4765-A6DA-2345C2E8707EQ35627390-16EDC8FE-7D76-428E-9A90-5D416D7168CFQ36411732-7AA4EB7E-0F78-4B5A-8DE1-3607A91EDC47Q37162895-DB25557D-DAB3-404D-9CD4-7EDE8E5CDA98Q37246263-B81C68AF-0C79-42F9-99B8-49059BBBB907Q37251490-8F199CCB-3F39-402D-8B7C-6370ED6158C6Q37358467-12653D82-B441-4F3A-BE85-0B0B10BA0633Q37394525-CD21B951-EC34-4287-8A60-1FD53CA3860DQ37496236-4E683205-CCC1-47B3-B4C4-AC94C5D6BB11Q37608355-EFE26FA9-AFF0-42A1-8C53-D570E3ACDBF6Q38217152-ED7CB7B2-7321-4CD6-B439-E9EC0232BD06Q38447545-D93E47D2-B4B7-40B1-92E7-9232A263A47FQ38483123-CACAA83C-E09A-476B-AC09-4656C98EB2B8Q38541932-5AAA9571-54CF-4CBC-A56F-6FB38845455AQ38664074-73D2FCA5-6A74-457B-90F0-90537B12152BQ39550267-07A34763-1EF0-4C13-A757-50A58149443CQ40610419-D501A31E-7A2F-4888-94AB-A8DEB5DD7C3BQ44714275-F4800144-7628-4B0E-AFB9-B4EED91055D4Q44770337-CFF496AE-AB94-4461-8518-49B03B841BA4Q45795390-E1E8B2D6-8384-4A82-A381-4A69656ED772Q46001195-F6EB64EC-D3CD-41AC-B16F-5AFA2F8396D0Q46249138-C05C2734-CB02-4816-AA48-019A7912270AQ46465498-CEB04C14-5B0B-44DC-92C1-C7F91A8D6D9DQ48039374-91847437-09D4-4C23-8E2E-B1269D81037CQ52597322-0E573815-86B6-4F46-A202-FA3CEBC020B5Q53158514-7B823143-D8B4-47C5-9B38-BFCCB5E6F81AQ53655058-B1876E99-A075-4DE2-8B89-396CC57321BDQ54688696-3583105C-67FC-455B-ADFB-EEF50E5B5E1F
P2860
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anticoagulant and antiplatelet ...... r bleeding risk and prognosis.
@en
Anticoagulant and antiplatelet ...... r bleeding risk and prognosis.
@nl
type
label
Anticoagulant and antiplatelet ...... r bleeding risk and prognosis.
@en
Anticoagulant and antiplatelet ...... r bleeding risk and prognosis.
@nl
prefLabel
Anticoagulant and antiplatelet ...... r bleeding risk and prognosis.
@en
Anticoagulant and antiplatelet ...... r bleeding risk and prognosis.
@nl
P2093
P921
P1476
Anticoagulant and antiplatelet ...... r bleeding risk and prognosis.
@en
P2093
Eduardo Pinar
Francisco Marín
Francisco Sogorb
Javier Pineda
José Antonio Hurtado
José Valencia
Juan M Ruiz-Nodar
Juan Ramón Gimeno
Mariano Valdés
P304
P356
10.1016/J.JACC.2007.11.035
P407
P577
2008-02-01T00:00:00Z